{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:29:10Z","timestamp":1773761350928,"version":"3.50.1"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2017,1,1]]},"DOI":"10.1248\/yakushi.16-00219","type":"journal-article","created":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T22:21:40Z","timestamp":1483222900000},"page":"111-120","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database"],"prefix":"10.1248","volume":"137","author":[{"given":"Eiji","family":"Kose","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapy, School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Uno","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, School of Pharmacy, Nihon University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Miyamoto S., Duncan G. E., Marx C. E., Lieberman J. A., <i>Mol. Psychiatry<\/i>, <b>10<\/b>, 79-104 (2005).","DOI":"10.1038\/sj.mp.4001556"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gebhardt S., H&auml;rtling F., Hanke M., Mittendorf M., Theisen F. M., Wolf-Ostermann K., Grant P., Martin M., Fleischhaker C., Schulz E., Remschmidt H., <i>Eur. Child Adolesc. Psychiatry<\/i>, <b>15<\/b>, 371-382 (2006).","DOI":"10.1007\/s00787-006-0544-5"},{"key":"3","unstructured":"3) Caroff S. N., Mann S. C., Campbell E. C., Sullivan K. A., <i>J. Clin. Psychiatry<\/i>, <b>63<\/b>, 12-19 (2002)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Conner D. F., Fletcher K. E., Wood J. S., <i>J. Clin. Psychiatry<\/i>, <b>62<\/b>, 967-974 (2001).","DOI":"10.4088\/JCP.v62n1209"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Glazer W. M., <i>J. Clin. Psychiatry<\/i>, <b>61<\/b>, 16-21 (2000).","DOI":"10.4088\/JCP.v61n0105"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kane J. M., <i>J. Clin. Psychiatry<\/i>, <b>65<\/b>, 16-20 (2004).","DOI":"10.4088\/JCP.v65n1102"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Leucht S., Corves C., Arbter D., Engel R. R., Li C., Davis J. M., <i>Lancet<\/i>, <b>373<\/b>, 31-41 (2009).","DOI":"10.1016\/S0140-6736(08)61764-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Peluso M. J., Lewis S. W., Barnes T. R., Jones P. B, <i>Br. J. Psychiatry<\/i>, <b>200<\/b>, 387-392 (2012).","DOI":"10.1192\/bjp.bp.111.101485"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Miller D. D., Caroff S. N., Davis S. M., Rosenheck R. A., McEvoy J. P., Saltz B. L., Riggio S., Chakos M. H., Swartz M. S., Keefe R. S., Stroup T. S., Lieberman J. A., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, <i>Br. J. Psychiatry<\/i>, <b>193<\/b>, 279-288 (2008).","DOI":"10.1192\/bjp.bp.108.050088"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Correll C. U., <i>J. Am. Acad. Child Adolesc. Psychiatry<\/i>, <b>47<\/b>, 9-20 (2008).","DOI":"10.1097\/chi.0b013e31815b5cb1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fujita T., <i>Jpn. J. Pharmacoepidemiol.<\/i>, <b>14<\/b>, 27-36 (2009).","DOI":"10.3820\/jjpe.14.27"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Umetsu R., Nishibata Y., Abe J., Suzuki Y., Hara H., Nagasawa H., Kinosada Y., Nakamura M., <i>Yakugaku Zasshi<\/i>, <b>134<\/b>, 299-304 (2014).","DOI":"10.1248\/yakushi.13-00225"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Umetsu R., Abe J., Ueda N., Kato Y., Nakayama Y., Kinosada Y., Nakamura M., <i>Yakugaku Zasshi<\/i>, <b>135<\/b>, 991-1000 (2015).","DOI":"10.1248\/yakushi.14-00231"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kato Y., Umetsu R., Abe J., Ueda N., Nakayama Y., Kinosada Y., Nakamura M., <i>J. Pharm. Health Care Sci.<\/i>, <b>1<\/b>, 15 (2015).","DOI":"10.1186\/s40780-015-0015-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ishiguro C., Nakamura S., Matsui K., <i>Jpn. J. Pharmacoepidemiol.<\/i>, <b>15<\/b>, 23-30 (2010).","DOI":"10.3820\/jjpe.15.23"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Rothman K. J., Lanes S., Sacks S. T., <i>Pharmacoepidemiol. Drug Saf.<\/i>, <b>13<\/b>, 519-523 (2004).","DOI":"10.1002\/pds.1001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) van Puijenbroek E. P., Bate A., Leufkens H. G., Lindquist M., Orre R., Egberts A. C., <i>Pharmacoepidemiol. Drug Saf.<\/i>, <b>11<\/b>, 3-10 (2002).","DOI":"10.1002\/pds.668"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sauzet O., Carvajal A., Escudero A., Molokhia M., Cornelius V. R., <i>Drug Saf.<\/i>, <b>36<\/b>, 995-1006 (2013).","DOI":"10.1007\/s40264-013-0061-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yamada M., Handa J., <i>Jpn. J. Pharmacoepidemiol.<\/i>, <b>19<\/b>, 23-30 (2014).","DOI":"10.3820\/jjpe.19.23"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ohtani H., Sawada Y., <i>Xenobio. Metabol. and Dispos<\/i>, <b>16<\/b>, 27-37 (2001).","DOI":"10.2133\/dmpk.16.27"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Divac N., Prostran M., Jakovcevski I., Cerovac N., <i>Biomed Res. Int.<\/i>, 656370 (2014).","DOI":"10.1155\/2014\/656370"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Onrust S. V., McClellan K., <i>CNS Drugs<\/i>, <b>15<\/b>, 329-337 (2001).","DOI":"10.2165\/00023210-200115040-00006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Deeks E. D., Keating G. M., <i>CNS Drugs<\/i>, <b>24<\/b>, 65-84 (2010).","DOI":"10.2165\/11202620-000000000-00000"},{"key":"24","unstructured":"24) Hosomi K., Park B., Inose R., Fujimoto M., Takada M., <i>Jpn. J. Drug Inform.<\/i>, <b>17<\/b>, 125-132 (2015)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Werner F. M., Cove&ntilde;as R., <i>Expert Opin. Drug Saf.<\/i>, <b>13<\/b>, 1031-1042 (2014).","DOI":"10.1517\/14740338.2014.935761"},{"key":"26","unstructured":"26) Matsui T., Umetsu R., Kato Y., Ueda N., Abe J., Nakayama Y., Hane Y., Kinosada Y., Nakamura M., <i>Jpn. J. Drug Inform.<\/i>, <b>17<\/b>, 145-154 (2015)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Trosch R. M., <i>J. Am. Geriatr. Soc.<\/i>, <b>52<\/b>, S266-S271 (2004).","DOI":"10.1111\/j.1532-5415.2004.52603.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Morikawa K., <i>Bull. Natl. Inst. Health Sci.<\/i>, <b>129<\/b>, 1-26 (2011).","DOI":"10.1093\/heapro\/dar010"}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/137\/1\/137_16-00219\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T14:21:35Z","timestamp":1718979695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/137\/1\/137_16-00219\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.16-00219","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}